This could lead to FDA approvals for treatment in obstructive sleep apnea, kidney disease, Alzheimers disease, liver disease, PCOS, and more
Moreover, there is an extension of this benefit for people with diabetes found in studies of those with obesity without T2D
Expect 1-2 pounds per week on average if adherence is good, though its not always linear
Most people describe "food noise" going quiet, the persistent mental chatter about meals and cravings fades
Additionally, incretin mimetics hold potential promise in many other indications (e.g., non-alcoholic steatohepatitis [NASH], short bowel syndrome) that are currently being studied or are yet to be clinically explored
With the power of Quicksilver Delivery Systems